Stock MBTC NOCTURNE ACQUISITION CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

News Nocturne Acquisition Corporation

Equities

MBTC

KYG6580S1140

Delayed Nasdaq
Other stock markets
 04:00:00 2024-04-03 pm EDT 		5-day change 1st Jan Change
11.66 USD -0.49% Intraday chart for Nocturne Acquisition Corporation 0.00% +0.08%
Apr. 03 Nocturne Acquisition Corporation(NasdaqCM:MBTC) dropped from NASDAQ Composite Index CI
Mar. 31 Cognos Therapeutics Inc. cancelled the acquisition of Nocturne Acquisition Corporation from a group of shareholders in a reverse merger transaction. CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Nocturne Acquisition Corporation(NasdaqCM:MBTC) dropped from NASDAQ Composite Index
CI
Cognos Therapeutics Inc. cancelled the acquisition of Nocturne Acquisition Corporation from a group of shareholders in a reverse merger transaction.
CI
Nocturne Acquisition Corporation Announces Management Changes
CI
Sector Update: Financial Stocks Ease Late Afternoon
MT
Sector Update: Financial
MT
Nocturne Acquisition Shares Jump as Stockholders' Vote on Merger With Cognos Therapeutics Postponed Further
MT
Nocturne Acquisition Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Chardan Engaged to Facilitate Nocturne Acquisition Corporation's Business Combination with Cognos Therapeutics, Inc., Paving the Way for NASDAQ Listing
AQ
Nocturne Acquisition Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Nocturne Acquisition Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Nocturne Acquisition Corporation Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Nocturne Acquisition Corporation Auditor Raises 'Going Concern' Doubt
CI
NOCTURNE ACQUISITION CORP : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)
AQ
NOCTURNE ACQUISITION CORP : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
NOCTURNE ACQUISITION CORP : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)
AQ
NOCTURNE ACQUISITION CORP : Regulation FD Disclosure (form 8-K)
AQ
NOCTURNE ACQUISITION CORP : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
NOCTURNE ACQUISITION CORP : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
Nocturne Acquisition in Deal to Merge With Cognos Therapeutics
MT
Cognos Therapeutics Inc. executed a definitive business combination agreement to acquire Nocturne Acquisition Corporation from Nocturne Sponsor, LLC, Polar Asset Management Partners Inc., Periscope Capital Inc, Sea Otter Advisors LLC and others for approximately $120 million in a reverse merger transaction.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MBTC Stock
  4. News Nocturne Acquisition Corporation